John F. Chappell

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R+3kCemYQnc+NVohZODZO3ANplzVadtXwiOgVj+0PEej+WGcI+d/me0D4/Ri6MSy Ky9tPVi/ttRhUCiC1L+K6A== 0001021408-03-003154.txt : 20030219 0001021408-03-003154.hdr.sgml : 20030219 20030219143528 ACCESSION NUMBER: 0001021408-03-003154 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030219 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-53269 FILM NUMBER: 03572444 BUSINESS ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 9198621000 MAIL ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHAPPELL JOHN F CENTRAL INDEX KEY: 0001053880 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 820 NEWTOWN RD CITY: VILLANOVA STATE: PA ZIP: 19085 BUSINESS PHONE: 5102939714 MAIL ADDRESS: STREET 1: 820 NEWTOWN RD CITY: VILLANOVA STATE: PA ZIP: 19085 SC 13G/A 1 dsc13ga.htm JOHN F. CHAPPELL John F. Chappell

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Amendment No. 5

Salix Pharmaceuticals, Ltd.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

795435 10 06

(CUSIP Number)

December 31, 2002

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

Explanatory Note

This Amendment No. 5 to Schedule 13G is being filed to amend and restate the reporting person’s Amendment No. 4 to Schedule 13G filed on February 14, 2003. This amendment reflects the reporting person’s disclaimer of beneficial ownership of 8,000 shares of the Issuer’s common stock held in trust for the reporting person’s adult children and with respect to which the reporting person is not the trustee.

CUSIP No. 795435 10 06


1.		Names of Reporting Person I.R.S. Identification No. of above persons (Entities Only) John F. Chappell

2.		Check the Appropriate Box if a Member of a Group (a) ¨ (b) ¨ Not Applicable

3.		SEC Use Only

4.		Citizenship or Place of Organization United States

NUMBER OF

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. Sole Voting Power

933,311

6. Shared Voting Power

7. Sole Dispositive Power

933,311

8. Shared Dispositive Power

9.		Aggregate Amount Beneficially Owned by Each Reporting Person 933,311

10.		Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ¨

11.		Percent of Class Represented by Amount in Row (9) 4.4%

12.		Type of Reporting Person IN

Last Update: 11/05/2002

Item 1(a) Name of Issuer

Salix Pharmaceuticals, Ltd

Item 1(b) Address of Issuer’s Principal Executive Offices

8540 Colonnade Center Drive, Suite 501, Raleigh, North Carolina 27615

Item 2(a) Name of Person Filing

John F. Chappell

Item 2(b) Address of Principal Business Office, or, if None, Residence

820 New Town Road, Villanova, Pennsylvania 19085

Item 2(c) Citizenship

United States

Item 2(d) Title of Class of Securities

Common Stock

Item 2(e) CUSIP Number

795435 10 06

Item 3. If this Statement is filed pursuant to § 240.13d-1(b) or § 240.13d-2(b) or (c), check whether the person filing is a:

(a)	¨	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c).
(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)	¨	An investment advisor in accordance with § 240.13d- 1(b)(1)(ii)(E);
(f)	¨	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	¨	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	¨	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	¨	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	¨	Group, in accordance with § 240.13d-1(b)(1)(ii)(J).
	x	NOT APPLICABLE

Page 3 of 5 Pages

Item 4. Ownership

(a)

Amount beneficially owned:

At December 31, 2002 Mr. Chappell beneficially owned an aggregate of 933,311 shares of the Issuer’s common stock, which includes options to purchase 17,917 shares of the Issuer’s common stock that were exercisable within 60 days of December 31, 2002 and 75,000 shares held in trust for the benefit of his spouse, children and grandchildren and with respect to which his spouse and two children are trustees. Mr. Chappell has not reported herein, and disclaims beneficial ownership with respect to, 8,000 shares held in trust as of December 31, 2002 for the benefit of his children and with respect to which neither Mr. Chappell nor his spouse is the trustee.

(b)

Percent of class:

4.4%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 933,311

(ii)

Shared power to vote or to direct the vote: 0

(iii)

Sole power to dispose or to direct the disposition of: 933,311

(iv)

Shared power to dispose or to direct the disposition of: 0

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ X ]

Item

6. Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item

7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not Applicable

Item

8. Identification and Classification of Members of the Group

Not Applicable

Item 9. Notice of Dissolution of Group

Not Applicable

Item 10. Certification

(a)

Not Applicable

(b)

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 4 of 5 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.



February 18, 2003
Date
/s/ John F. Chappell

Page 5 of 5 Pages

-----END PRIVACY-ENHANCED MESSAGE-----